Regulation by nicotine of its own receptors

Drug Development Research

Volumn 38, Issue 3-4, 1996, Pages 136-148

  Lukas, Ronald J ^a   Ke, Lei ^a   Bencherif, Merouane ^b   Eisenhour, Cynthia M ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b R J REYNOLDS TOBACCO COMPANY   (United States)

Author keywords

Acetylcholine; Chronic; Desensitization; Nicotine; Nicotinic receptors; Upregulation

Indexed keywords

NEUROTRANSMITTER RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

BRAIN; CELL LINE; DESENSITIZATION; DOSE RESPONSE; HUMAN; IN VITRO STUDY; NONHUMAN; PROTEIN FAMILY; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SMOKING;

EID: 12644303227     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199607/08)38:3/4<136::AID-DDR2>3.0.CO;2-N     Document Type: Review

References (67)

1. Abood LG (1984): Mechanisms of tolerance and dependence: An overview. In Sharp CW (ed): Mechanisms of Tolerance and Dependence, NIDA Research Monograph 54, DHHS Publication No. (ADM) 84-1330. Washington, DC: US Government Printing Office, pp 4-11.
2. Alkondon M, Albuquerque EX (1993): Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265:1455-1473.
3. Arneric SP, Sullivan JP, Williams M (1995): Neuronal nicotinic acetylcholine receptors: Novel targets for central nervous system therapeutics. In Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 95-110.
4. Aylwin ML, White MM (1992): Forskolin acts as a non-competitive inhibitor of nicotinic acetylcholine receptors. Mol Pharmacol 41:908-913.
5. Bencherif M, Lukas RJ (1993a): Paradoxical regulation of nicotinic acetylcholine receptors (nAChR) in TE671/RD human cells: Functional effects of acute/chronic exposure to agonist. J Neurochem 61:522.
6. Bencherif M, Lukas RJ (1993b): Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: A possible functional role of the cytoskeleton. J Neurochem 61:852-864.
7. Bencherif M, Lukas RJ (1993c): Effects of dibutyryl cyclic AMP or forskolin on muscle- or ganglia-type nicotinic receptor function are cyclic AMP independent. Soc Neurosci Abs 19:1133.
8. Bencherif M, Fowler K, Lukas RJ, Lippiello PM (1994): Nicotine up-regulates high affinity α4β2 nicotinic acetylcholine receptors through post-translational mechanisms. Int Symp Nicotine P43.
9. Bencherif M, Fowler K, Lukas RJ, Lippiello PM (1995a): Mechanisms of upregulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther 275:987-994.
10. Bencherif M, Eisenhour CM, Prince RJ, Lippiello PM, Lukas RJ (1995b): The "calcium antagonist" TMB-8 [3,4,5-trimethoxy benzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes. J Pharmacol Exp Ther 275:1418-1426.
11. Benowitz NL, Porchet H, Jacob P III (1989): Nicotine dependence and tolerance in man: Pharmacokinetic and pharmacodynamic investigations. In Nordberg A, Fuxe K, Holmstedt B (eds): Prog Brain Res 79:279-287.
12. Benwell MEM, Balfour DJK, Anderson JM (1988): Evidence that tobacco smoking increases the density of nicotine binding sites in human brain. J Neurochem 50:1243-1247.
13. Boyd ND (1987): Two distinct phases of desensitization of acetylcholine receptors of clonal rat PC12 cells. J Physiol 89:45-67.
14. Changeux J-P, Galzi J-L, Devillers-Thiery A, Bertrand D (1992): The functional architecture of the acetylcholine receptor explored by affinity labeling and site directed mutagenesis. Q Rev Biophys 25:395-432.
15. Collins AC, Luo Y, Selvaag S, Marks MJ (1994): Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion. J Pharmacol Exp Ther 271:125-133.
16. Collins AC, Marks MJ (1991): Progress toward the development of animal models of smoking-related behaviors. J Addict Disord 10:109-126.
17. Eisenhour CM, Lukas RJ (1995): Interactions of tachykinins with diverse nAChR subtypes. Soc Neurosci Abs 21:1336.
18. Eisenhour CM, Puchacz E, Lukas RJ (1993): Calcium ion influx in clonal cell lines expressing nicotinic acetylcholine receptors. Soc Neurosci Abs 19:1533.
19. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S (1994): α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79:705-711.
20. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ (1992): A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41:31-37.
21. 3H]dopamine release from mouse striatal synaptosomes. J Neurochem 62:1390-1394.
22. 3H]tetraphenylphosphonium by cerebral cortical synaptosomes. J Neurochem 60:687-695.
23. Hulihan-Ciblin BA, Lumpkin MD, Kellar KJ (1990): Effects of chronic administration of nicotine on prolactin release in the rat: Inactivation of prolactin response by repeated injections of nicotine. J Pharmacol Exp Ther 252:21-25.
24. Jarvik ME (1991): Beneficial effects of nicotine. In West R, Grunberg NE (eds): Br J Addict 86:571-576.
25. Ke L, Lukas RJ (1994): Effects of steroid exposure on ligand binding and functional activity of nicotinic acetylcholine receptors. Soc Neurosci Abs 20:1136.
26. Ke L, Eisenhour CM, Lukas RJ (1995a): Effects of chronic nicotine exposure on expression of diverse nicotinic acetylcholine receptor subtypes. J Neurochem 64:S58A.
27. Ke L, Eisenhour CM, Bencherif M, Lukas RJ (1995b): On mechanisms of nicotine-induced upregulation and functional inactivation of diverse nicotinic receptor subtypes. Soc Neurosci Abs 21:1338.
28. Kemp G, Edge M (1987): Cholinergic function and alpha-bungarotoxin binding in PC12 cells. Mol Pharmacol 32:356-363.
29. Keyser KT, Britto LRG, Schoepfer R, Whiting P, Cooper J, Conroy W, Brozozowska-Prechtl A, Karten JH, Lindstrom J (1993): Three subtypes of α-bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina, J Neurosci 13:442-454.
30. 3H]N-methylcarbamylcholine binding sites in rat brain. J Neurochem 52:483-491.
31. Lapin EP, Maker HS, Sershen H, Lajtha A (1989): Action of nicotine on accumbens dopamine and attenuation with repeated administration. Eur J Pharmacol 160:53-59.
32. Lukas RJ (1989): Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma. J Pharmacol Exp Ther 251:175-182.
33. 3H-acetylcholine binding sites. J Pharmacol Exp Ther 253:51-57.
34. Lukas RJ (1991): Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal lines. J Neurochem 56:1134-1145.
35. Lukas RJ (1993): Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line. J Pharmacol Exp Ther 265:294-302.
36. Lukas RJ (1995): Diversity and patterns of regulation of nicotinic receptor subtypes. Ann NY Acad Sci 757:153-168.
37. Lukas RJ, Bencherif M (1992): Heterogeneity and regulation of nicotinic acetylcholine receptors. Int Rev Neurobiol 34:25-131.
38. Lukas RJ, Bencherif M (1993): Cooperativity between cyclic AMP- and C-kinase-dependent processes in the regulation of nicotinic acetylcholine receptor expression and function. Soc Neurosci Abs 19:1133.
39. Lukas RJ, Norman SA, Lucero L (1993): Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol Cell Neurosci 4:1-12.
40. Lukas RJ, Lucero L, Eisenhour CM, Brockey A, Bohayets M (1995): Functional pharmacological profiles of diverse nicotinic acetylcholine receptor subtypes: Mechanisms of activation and inhibition. Soc Neurosci Abs 21:1335.
41. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, Collins AC (1992): Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12:2765-2784.
42. Marks MJ, Grady SD, Collins AC (1993): Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 266:1268-1276.
43. McGee R, Liepe B (1984): Acute elevation of cyclic AMP does not alter the ion-conducting properties of the neuronal nicotinic acetylcholine receptor of PC12 cells. Mol Pharmacol 26:51-56.
44. Nishizawa Y, Seamon KB, Daly JW, Aronstam RS (1990): Effects of forskolin and analogues on nicotinic receptor-mediated sodium flux, voltage-dependent calcium flux, and voltage-dependent rubidium efflux in pheochromocytoma PC12 cells. Cell Mol Neurobiol 10:351-368.
45. Noble MD, Brown TH, Peacock JH (1978): Regulation of acetylcholine receptor levels in mouse muscle cell cultures. Proc Natl Acad Sci USA 75:3488-3492.
46. Peng X, Gerzanich V, Anand R, Whiting P, Lindstrom J (1994): Nicotine-induced increase in neuronal nicotinic receptors results in a decrease in the rate of receptor turnover. Mol Pharmacol 46:523-530.
47. Pomerleau OF (1986): Nicotine as a psychoactive drug: Anxiety and pain reduction. Psychopharmacol Bull 22:865-869
48. Puchacz EP, Buisson B, Bertrand D, Lukas RJ (1994): Functional expression of nicotinic acetylcholine receptors containing rat α7subunits in human SH-SY5Y neuroblastoma cells. FEBS Lett 354:155-159.
49. Robinson D, McGee R Jr (1985): Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor or PC12 cells. Mol Pharmacol 27:409-417.
50. Rowell PP, Wonnacott S (1990): Evidence for functional activity of upregulated nicotine binding sites in rat striatal synaptosomes. J Neurochem 55:2105-2110.
51. Russell MAH (1987): Nicotine intake and its regulation by smokers. In Martin WR, Van Loon GR, Iwamoto ET, Davis L (eds): Tobacco Smoking and Nicotine: A Neurobiological Approach. New York: Plenum Press, pp 25-50.
52. Russell MAH (1988): Nicotine uptake by smokers: are rates of adsorption or steady-state kinetics more important? In Rand MJ, Thurau K (eds): Pharmacology of Nicotine. New York: IC-SU Press, pp 375-402.
53. Sandersson EM, Drasdo AL, McCrea K, Wonnacott S (1993). Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific. Brain Res 617:349-352.
54. Sargent PB (1993): The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403-443.
55. Sharp BM, Beyer HS (1986): Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J Pharmacol Exp Ther 238:486-491.
56. Sharp BM, Beyer HS, Levine AS, Moreley JE, McAllen KM (1987): Attenuation of plasma prolactin response to restraint stress after acute and chronic administration of nicotine to rats. J Pharmacol Exp Ther 241:438-442.
57. Siegel HN, Lukas RJ (1988): Nicotinic agonists regulate alphabungarotoxin binding sites of TE671 human medulloblastoma cells. J Neurochem 50:1272-1278.
58. Simasko SM, Soares JR, Weiland GA (1986): Two components of carbamylcholine-induced loss of nicotinic acetylcholine receptor function in the neuronal cell line PC12. Mol Pharmacol 30:6-12.
59. Smith MA, Margiotta JF, Franco A Jr, Lindstrom JM, Berg DK (1986): Cholinergic modulation of an acetylcholine receptor-like antigen on the surface of chick ciliary ganglion neurons in cell culture. J Neurosci 6:946-953.
60. Stallcup WB, Patrick J (1980): Substance P enhances cholinergic receptor desensitization in a clonal nerve cell line. Proc Natl Acad Sci USA 77:634-638.
61. Stolerman IP (1990): Behavioural pharmacology of nicotine: Implications for multiple brain nicotinic receptors. CIBA Found Symp 152:3-16.
62. Taylor P (1985a): Canglionic Stimulating and Blocking Agents. In Gilman AC, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics. 7th Ed. New York: Macmillan, pp 215-221.
63. Taylor P (1985b): Neuromuscular Blocking Agents. In Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics. 7th Ed. New York: Macmillan, pp 222-235.
64. US DHHS (1988): The Health Consequences of Smoking: Nicotine Addiction, A Report of the Surgeon General DHHS (CDC) 88-8406. Washington, DC: US Government Printing Office, 618 pp.
65. Vernallis AB, Conroy WG, Berg DK (1993): Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron 10:451-464.
66. Whiting P, Lindstrom J (1987): Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc Natl Acad Sci USA 84:595-599.
67. Wonnacott S (1990): The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11:216-219.